Nanomedicine therapeutic approaches to overcome cancer drug resistance

od Markman, Janet L., Rekechenetskiy, Arthur, Holler, Eggehard, Ljubimova, Julia Y.
Wydane w Adv Drug Deliv Rev (2013)

Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid)

od Patil, Rameshwar, Portilla-Arias, Jose, Ding, Hui, Konda, Bindu, Rekechenetskiy, Arthur, Inoue, Satoshi, Black, Keith L., Holler, Eggehard, Ljubimova, Julia Y.
Wydane 2012

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

od Ljubimova, Julia Y., Ding, Hui, Portilla-Arias, Jose, Patil, Rameshwar, Gangalum, Pallavi R., Chesnokova, Alexandra, Inoue, Satoshi, Rekechenetskiy, Arthur, Nassoura, Tala, Black, Keith L., Holler, Eggehard
Wydane 2014

Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer’s Disease()

od Patil, Rameshwar, Gangalum, Pallavi R., Wagner, Shawn, Portilla-Arias, Jose, Ding, Hui, Rekechenetskiy, Arthur, Konda, Bindu, Inoue, Satoshi, Black, Keith L., Ljubimova, Julia Y., Holler, Eggehard
Wydane w Macromol Biosci (2015)

Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment

od Ljubimova, Julia Y., Portilla-Arias, Jose, Patil, Rameshwar, Ding, Hui, Inoue, Satoshi, Markman, Janet L., Rekechenetskiy, Arthur, Konda, Bindu, Gangalum, Pallavi R., Chesnokova, Alexandra, Ljubimov, Alexander V., Black, Keith L., Holler, Eggehard
Wydane 2013

MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain

od Patil, Rameshwar, Ljubimov, Alexander V., Gangalum, Pallavi R., Ding, Hui, Portilla-Arias, Jose, Wagner, Shawn, Inoue, Satoshi, Konda, Bindu, Rekechenetskiy, Arthur, Chesnokova, Alexandra, Markman, Janet L., Ljubimov, Vladimir A., Li, Debiao, Prasad, Ravi S., Black, Keith L., Holler, Eggehard, Ljubimova, Julia Y.
Wydane w ACS Nano (2015)

Blockade of a laminin-411 - Notch axis with CRISPR/Cas9 or a nanobioconjugate inhibits glioblastoma growth through tumor-microenvironment crosstalk

od Sun, Tao, Patil, Rameshwar, Galstyan, Anna, Klymyshyn, Dmytro, Ding, Hui, Chesnokova, Alexandra, Cavenee, Webster K., Furnari, Frank B., Ljubimov, Vladimir A., Shatalova, Ekaterina S., Wagner, Shawn, Li, Debiao, Mamelak, Adam N., Bannykh, Serguei I., Patil, Chirag G., Rudnick, Jeremy D., Hu, Jethro, Grodzinski, Zachary B., Rekechenetskiy, Arthur, Falahatian, Vida, Lyubimov, Alexander V., Chen, Yongmei L., Leoh, Lai S., Daniels-Wells, Tracy R., Penichet, Manuel L., Holler, Eggehard, Ljubimov, Alexander V., Black, Keith L., Ljubimova, Julia Y.
Wydane w Cancer Res (2019)